Both expression of O6-methylguanine-DNA methyltransferase (MGMT) and p53 mutations have been linked to TMZ sensitivity of glioblastoma cell lines (Hermisson et al. 2006; Lee 2016). The gene discussed is MGMT; the disease is glioblastoma.